New hemophilia treatment tested against current options
NCT ID NCT06579144
Summary
This study is comparing how long a new hemophilia A treatment (efanesoctocog alfa) stays active in the bloodstream versus two existing treatments. It involves 24 adult men with severe hemophilia A who are already using one of the comparison treatments. Each participant will receive both their current treatment and the new treatment at different times, with blood tests to measure how long each one remains effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sobi Investigational Site
RECRUITINGSofia, Bulgaria
Contact
-
Sobi Investigational Site
RECRUITINGOldenburg, Germany
Contact
-
Sobi Investigational Site
RECRUITINGMilan, Italy
Contact
-
Sobi Investigational Site
NOT_YET_RECRUITINGNaples, Italy
Contact
-
Sobi Investigational Site
RECRUITINGA Coruña, Spain
Contact
-
Sobi Investigational Site
RECRUITINGValencia, Spain
Contact
-
Sobi Investigational Site
RECRUITINGZaragoza, Spain
Contact
-
Sobi Investigational site
RECRUITINGFrankfurt, Germany
Contact
Conditions
Explore the condition pages connected to this study.